Literature DB >> 17021766

In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.

Kazumoto Katagiri1, Shoko Arakawa, Yutaka Hatano.   

Abstract

Alopecia areata (AA) has been considered to be supported by an aberrant expression of IFN-gamma as a result of antigen dependent immune response. On the other hand, AA sometimes concurs with atopic diseases, although the mechanism of the concurrence is not clear. This study was designed to elucidate the immune status of AA and the similarity between AA and atopic dermatitis (AD) by analysis of in vivo levels of mRNA of Th1, Th2, and suppressive cytokines of peripheral blood mononuclear cells (PBMC). Using semiquantitative RT-PCR, the levels of cytokine mRNA were measured in freshly isolated PBMC of 47 patients with AA, 15 patients with AD, and 12 healthy controls (HC). The levels of IL-4, IFN-gamma, and TGF-beta1 mRNA were lower in patients with AA than those in HC. The levels of IL-10 mRNA in AA were comparable with those in HC. Decreased levels of IFN-gamma and TGF-beta1 were also shown in patients with AD. These results indicated a similarity (decreased levels of IFN-gamma and TGF-beta1) between AD and AA based on the cytokine profile. In addition, decreased levels of IL-4 mRNA in AA might also explain the experience that the severity of atopic disease coincident with AA is mild in the most of cases. Next, we compared the levels of these cytokine mRNA among the three subgroups of AA that were categorized based on the severity of the symptoms: mild, severe and totalis. Although there was no significant difference between any combinations of the subgroups, there was a tendency to increase the levels of IFN-gamma mRNA and to decrease the levels of IL-4 mRNA according to the severity of alopecia. However, the levels of IFN-gamma mRNA in any subgroups were less than those of HC. These results suggest that IFN-gamma is therefore involved in the pathogenesis of AA, although the information from PBMC is limited. In conclusion, AA might be induced by an aberrant expression of IFN-gamma in individuals whose PBMC produce low amounts of IFN-gamma and TGF-beta1. Further analysis is therefore required to investigate the phenotypes of the population in PBMC with or without reference to regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021766     DOI: 10.1007/s00403-006-0700-2

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  8 in total

1.  The role of cytokines in the pathomechanism of cutaneous disorders.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

2.  Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.

Authors:  Enas A S Attia; Dina El Shennawy; Ashraf Sefin
Journal:  Dermatol Res Pract       Date:  2010-06-30

3.  Hair regrowth in alopecia areata patients following Stem Cell Educator therapy.

Authors:  Yanjia Li; Baoyong Yan; Hepeng Wang; Heng Li; Quanhai Li; Dong Zhao; Yana Chen; Ye Zhang; Wenxia Li; Jun Zhang; Shanfeng Wang; Jie Shen; Yunxiang Li; Edward Guindi; Yong Zhao
Journal:  BMC Med       Date:  2015-04-20       Impact factor: 8.775

4.  Total serum immunoglobulin E in patients with alopecia areata.

Authors:  Ola Ahmed Bakry; Rania Mohamed Azmy El Shazly; Mohamed Ahmed Basha; Hanan Mostafa
Journal:  Indian Dermatol Online J       Date:  2014-04

5.  Serum concentrations of selected proinflammatory cytokines in children with alopecia areata.

Authors:  Katarzyna Tabara; Magdalena Kozłowska; Anna Jędrowiak; Wojciech Bienias; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

Review 6.  Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.

Authors:  Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Tanaporn Anuntrangsee; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

7.  Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls.

Authors:  Marta Wojciechowska-Zdrojowy; Alina Jankowska-Konsur; Danuta Nowicka-Suszko; Jacek C Szepietowski; Anita Hryncewicz-Gwóźdź
Journal:  Postepy Dermatol Alergol       Date:  2022-01-07       Impact factor: 1.837

Review 8.  The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.

Authors:  Anna Waśkiel-Burnat; Marta Osińska; Anna Salińska; Leszek Blicharz; Mohamad Goldust; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.